4 completed, 1 terminated, 1 withdrawn. 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Thyrotropin-Releasing Hormone: new trials by email Literature Review of Thyrotropin-Releasing Hormone trials Research Report on Thyrotropin-Releasing Hormone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer Thyrotropin Releasing Hormone (TRH), levothyroxine, Hypothyroidism QOL questionnaire - Thyroid Cancer | Phase 1 | Withdrawn | Memorial Sloan Kettering Cancer Center | 2021-04-27 | 2023-02-21 | |
| Mechanistic Study of Subclinical Hypothyroidism In the Elderly Levothyroxine, Liothyronine, Thyrotropin-Releasing Hormone - Subclinical Hypothyroidism | Not applicable | Completed | University of Pennsylvania | 14 | 2015-01-01 | 2021-03-09 |
| Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue Thyrotropin releasing hormone (TRH), Placebo - Cancer-related Fatigue | Phase 2 | Terminated | UConn Health | 11 | 2006-12-01 | 2017-12-28 |
| Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities TRH (Thyrotropin Releasing Hormone) - Healthy, Pituitary Disease | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 96 | 2003-02-07 | 2018-08-08 |
| Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants thyrotropin-releasing hormone - Respiratory Distress Syndrome | Not applicable | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 996 | 1998-05-01 | 2005-06-24 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery betamethasone, dexamethasone, thyrotropin-releasing hormone - Respiratory Distress Syndrome | Phase 3 | Completed | National Center for Research Resources (NCRR) | 1090 | 1993-08-01 | 2005-06-24 |
Hypothyroidism (2) · Infant, Newborn, Diseases (2) · Rare Diseases (2) · Respiratory Distress Syndrome (2) · Respiratory Tract Diseases (2) · Thyroid Diseases (2) · Pituitary Diseases (1) · Pituitary Neoplasms (1) · Thyroid Neoplasms (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Memorial Sloan Kettering Cancer Center (1) · National Center for Research Resources (NCRR) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · UConn Health (1) · University of Pennsylvania (1)
United States (3)
Roberta A. Ballard (2) · Andrew Winokur, MD PhD (1) · Anne R Cappola, MD, ScM (1) · Joanna Klubo-Gwiezdzinska, M.D. (1) · Stephanie Fish, MD (1)
K24AG042765 (1)